Physician profile
Philip Cleves
NPI 1720737513
$339.14
in general payments reported to CMS, 2019-2025
11 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $46.74 · 2024: $40.32 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $92.84 | 2023-2025 | |
| Eisai INC. | $48.24 | 2025 | |
| Merck Sharp & Dohme LLC | $38.61 | 2025 | Capvaxive, Gardasil 9 |
| Tolmar, INC. | $30.74 | 2025 | Jatenzo |
| Dexcom, INC. | $24.26 | 2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $22.27 | 2025 | |
| Exact Sciences Corporation | $19.83 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $18.67 | 2025 | |
| Glaxosmithkline, LLC. | $15.64 | 2024 | Trelegy Ellipta, Arexvy |
| Abbvie INC. | $14.45 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $13.59 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Cleves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.